consolidated financial statements of the Company and its subsidiaries for the year ended 31st December 2019. In 2019, the Company achieved consolidated profits (attributable to equity holders of the parent) of
[‐4%] and higher salaries expense [‐1%]. Page 1 of 3 Operating Profit Analysis Year‐on‐year operating profits were 40% lower at THB 355m in Q118 compared to THB 588m in Q117. The Operating margin was 7
%. Net profit For the year ended 31 December 2018, the Company and its subsidiaries had net profits of THB 227.68 million, an increase of THB 40.01 million or 21.32% from the year of 2017. Although the
services increased 9.66% and (3) Revenue from sales of products increased 1,016.24%. Net profit For the nine-month period ended 30 September 2018, the Company and its subsidiaries had net profits of THB
treatments was derived from cost incurred from cost of goods sold, doctor fee, depreciation and infrastructure expense. Selling Expenses The selling expenses for the 1st quarter of Year 2019 and 2020 were in
195% as compared to 3Q 2018 by 41 million Baht. The total gross profits for 3Q 2019 was 87 million Baht (39% of total revenue), decreased by 175 million Baht as compared to 3Q 2018 as a result of
operating result for nine months Comparing accumulated operating results for 9 months with the same period of the prior year, the group’s profits increased by Baht 24.07 million, due to the following reasons
of 35% yoy. The increase was mainly the accounting expense stemming from the revised down of social security income of 4Q’17 for amount of THB 10.7 million. Without taken into account this extra
billion in year 2016. Sales Revenue in USD terms increased by 9% to USD 635 million in 2017 from USD 581 million in 2016. Operating profits increased 16% to THB 2,290 million Baht in 2017 from THB 1,969m
proportionate of house brand products in 1H19 was 64% increased from previous period resulted in higher gross profits margin. For the proportion of other income to total revenue, it’s slightly decreased compared